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Aim: To compare propofol combinations with low induction doses of remifentanil and fentanyl in respect to the complication frequency
and efficiency in ease of procedure in children undergoing esophagogastroduodenoscopy.
Materials and methods: Sixty-four patients, aged 3–14 years and undergoing elective esophagogastroduodenoscopy, were included in
the study. The patients received an induction dose of 0.25 µg kg–1 remifentanil and 2 mg kg–1 propofol (group R), or 0.5 µg kg–1 fentanyl
and 2 mg kg–1 propofol (group F) before the procedure. The procedure began with a sedation score of ≥5. Hemodynamic values,
movement, ease and duration of the procedure, the time to awakening, and any requirement for additional doses of propofol/opioids
and adverse events were recorded.
Results: Although frequency of apnea after induction was higher and the duration of apnea was longer in group R, during procedure
and postprocedure follow-up, there were no apnea episodes in either group (P < 0.05, P > 0.05). Intraoperative respiratory rate, time to
eye opening, opioid consumption, and duration of recovery were significantly shorter in group R (P < 0.05).
Conclusion: Remifentanil, when combined with propofol, can provide as efficient and safe anesthesia as fentanyl propofol combination
for procedures like esophagogastroduodenoscopy.
Key words: Anesthesia, pediatric, remifentanil, fentanyl, upper gastric endoscopy

1. Introduction
As a parallel to the increased usage of endoscopic
examination of the upper gastrointestinal system on an
outpatient basis, the need for anesthesia and sedation
gradually increases, especially in children, who need
deeper sedation than adults (1,2). Ideal pediatric
endoscopy requires control of anxiety, amnesia, pain, and
combative behavior, and prompt patient recovery with
high safety and effectiveness (3).
Anesthetic agents with rapid onset and short duration
of action along with minimum suppression of the vital
signs are preferred for outpatient procedures (4). Propofol,
which is preferred due to its short duration of action,
has been reported to provide a deep sedation and rapid
recovery, but when used alone, propofol cannot provide
adequate immobility and a relatively higher dose of
propofol is required to enable adequate sedation (2,5,6).
At times, such high doses may result in hypotension,
respiratory depression, and unintended duration of
anesthesia (7).
* Correspondence: vahapsaricicek@hotmail.com

Opioids have been reported to reduce the need for
propofol, in addition to providing hemodynamic stability
and increasing the performance of the endoscopist
by providing ease of procedure (2,6–10). Different
combinations of these agents were studied in pediatric
anesthesia literature (2,8,10,11). Fentanyl is a frequently
used opioid agent proven to be efficient and safe for
pediatric procedures, but its potency is intermediate and
blood clearance is slow, which usually leads to much
longer anesthesia duration than that of endoscopic
procedures (2,8,10,11). Remifentanil, which is a more
potent agent with shorter duration of action, is frequently
used in pediatric outpatient anesthesia in bone marrow
aspiration, bronchoscopy, and cardiac catheterization,
as well as in laser photocoagulation in premature infants
(12–15). Remifentanil has been used in adult endoscopic
procedures in combination with propofol, which gave
better results than fentanyl (9). Results of pediatric studies
that compared remifentanil with fentanyl in combination
with propofol are contradictory and study protocols are
relatively complicated.
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We planned a study with a much lower induction dose
of opioids with propofol (remifentanil and fentanyl) and
additive doses that were given when required during the
procedure in order to decrease complication rates and
increase the quality and efficiency of anesthesia in pediatric
esophagogastroduodenoscopy (EGD) procedures.
2. Materials and methods
The effect of propofol and remifentanil sedation was
prospectively studied in 64 unpremedicated children
undergoing gastrointestinal endoscopy under sedation.
The children were aged between 3 and 14 years and with
American Society of Anesthesiologist (ASA) scores of
I. Exclusion criteria were as follows: having pulmonary
or cardiac insufficiency, history of hypersensitivity to
any medication used in the study, and history of severe
vomiting, bleeding, or regurgitation. Approval was
obtained from the institutional local ethics committee of
Gaziantep University and informed consent was obtained
from parents of the children.
The patients were randomly assigned to one of the study
groups using sealed numbered envelopes. In group R (n =
32), EGD was performed after 0.25 µg kg–1 bolus dose of
remifentanil (Ultiva, GlaxoSmithKline, United Kingdom)
followed by 2 mg kg–1 propofol that was slowly injected
(Propofol, Fresenius Kabi, Germany) before the procedure
(16). The children in group F (n = 32) received 0.5 µg kg–1
bolus dose of fentanyl (Fentanyl-Janssen, Janssen-Cilag,
Belgium) followed by 2 mg kg–1 propofol that was slowly
injected. All of the children received oxygen via a nasal
cannula (4 L min–1) during the procedure. All of the EGD

procedures were performed by means of a pediatric fiber
optic video gastroscope (Fujinon EG, Saitama, Japan) by an
experienced pediatric gastroenterologist in the endoscopy
room. Physiological parameters of all patients, such as mean
arterial pressure (MAP), heart rate (HR), respiratory rate
(RR), and oxygen saturation (SpO2) were monitored via a
computerized monitor. The measurements were obtained
before the administration of the drugs, before inserting
the gastroscope, every 3 min during the procedure, every
5 min after the procedure until the patient’s Aldrete score
was above 8 in the recovery room, and before discharge.
Head and body movements, coughing and gagging during
the gastroscope insertion, apnea lasting for 20 s or longer,
the duration of the procedure, the time to awakening,
and any requirement for additional doses of propofol
and opioids were recorded (Table 1) (17). Patients who
developed apnea were ventilated using oxygen via a
balloon mask. Ease of the procedure was assessed on a
scale of 1 to 4 by the same gastroenterologist immediately
after the EGD (1: very easy, 2: fairly easy, 3: difficult, and
4: failure to complete examination), who was unaware of
the drug combination that was administered. The patients’
movements during the insertion of the gastroscope were
graded on a scale of 0 to 3, where 0: none, 1: mild (no
additional assistance needed), 2: moderate (the child
needed to be kept still by an assistant), and 3: severe
(procedure could not be carried out). An additional dose
of 0.5 mg kg–1 propofol was only administered when the
movement score exceeded 1, and 0.5 mg kg–1 propofol plus
0.2 µg kg–1 fentanyl or remifentanil (maximum of 1 µg kg–1
remifentanil and 2 µg kg–1 fentanyl) were administered

Table 1. PACU recovery and discharge scorings (modified Aldrete score).*
Parameters

Description of the patient

Activity level

Moves all extremities voluntarily/on command
Moves 2 extremities
Cannot move extremities

2
1
0

Respiration

Breathes deeply and coughs freely
Is dyspneic, with shallow, limited breathing
Is apneic

2
1
0

Circulation (blood pressure)

Is 20 mmHg > preanesthetic level
Is 20 to 50 mmHg > preanesthetic level
Is 50 mmHg > preanesthetic level

2
1
0

Consciousness

Is fully awake
Is arousable on calling
Is not responding

2
1
0

Oxygen saturation as determined
by pulse oximetry

Has level > 90% when breathing room air
Requires supplemental oxygen to maintain level > 90%
Has level < 90% with oxygen supplementation

2
1
0

*Maximum total score is 10; a score of ≥9 is required for discharge.
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when the movement scores exceeded 2 or 3. The level of
sedation was assessed by a modified Ramsay scale (Table
2) (18). The procedure began with a sedation score of ≥5,
and the time to awakening was recorded when the patient
attained a sedation score of 3 (induction of anesthesia–eye
opening with verbal orders). The awakening was recorded
by a nurse who was blinded to the kind of opioid that was
used. Adverse effects were recorded during the procedure
and in the recovery room. Children with an Aldrete score
of ≥9 (Table 1), oriented, cooperating, and with SpO2 of
>95 at room conditions were discharged from the recovery
room. Duration of recovery (from the end of the procedure
to discharge from the recovery room) was recorded.
Perioperative adverse events like dizziness, hypotension,
bradycardia, bronchospasm, apnea, nausea, vomiting, and
duration of apnea periods were also recorded. Balloonmask ventilation was applied to the children when the
SpO2 was <90 and/or apnea lasted for 20 s or longer
(prolonged apnea). When spontaneous ventilation started,
children ventilated via a balloon mask device were allowed
to continue with the procedure. Adverse events with no
need for special treatment were considered as being
minor, whereas those requiring pharmacologic treatment
or ventilatory support were defined as significant adverse
events.
Table 2. Ramsey sedation scores.
Nervous, agitated, and/or restless

1

Cooperative, orientated, quiet patient

2

Only obeying orders

3

Sleeping, hitting the glabella, and responding to high
voices suddenly

4

Sleeping, hitting the glabella, and responding to high
voices slowly

5

No response to any of this stimulation

6

2.1. Statistics
With reference to locally collected data, a study population
size of the 64 patients was calculated to give a confidence
interval of 95% in opioid consumption. All data were
expressed as mean ± standard deviation (SD). For statistical
analysis, comparison of groups was carried out using a
nonparametric Mann–Whitney U test for movement
score, ease of operation, and balloon-mask ventilation
(patients with apnea duration longer than 20 s). Student’s
t-test was used for age, weight, duration of operation, RR,
HR, MAP, SpO2, propofol and opioid consumption, time
of awakening, duration of postanesthesia care unit (PACU)
stay, number and duration of apnea, and chi-square results
for the evaluation of the remaining data (sex, ASA score,
adverse events). In-group comparisons according to the
baseline values of RR, HR, MAP, and SpO2 were carried out
with a paired t-test. All statistical analyses were performed
with SPSS 13.0 (SPSS Inc., Chicago, IL, USA). P < 0.05 was
considered statistically significant.
3. Results
The clinical and demographic characteristics of the patients
in both groups were similar (Table 3). The indications for
the need of EGD in our patients were dyspepsia, suspicion
of celiac disease, hematemesis etiology, foreign body
extraction, and dysphagia.
Perioperative blood pressure was similar in both
groups (Table 4). However, during the procedure, HR
was significantly higher in the fentanyl group (P < 0.05).
Intraoperative and postoperative hemodynamic values
did not differ significantly according to baseline values
between groups.
Apnea occurred after induction and reversed before the
beginning of the procedure in all of the cases. Prolonged
apnea was recorded in 14 (43.8%) children in group R and
in 11 (33.3%) children in group F. None of them required
endotracheal intubation. Mean duration of apnea as
detected in groups R and F was 23.9 ± 19 and 18.8 ± 16.8
s, respectively, and the difference was not significant (P >
0.05, Table 5). There was no other adverse event during

Table 3. Demographic values.

Age (years)
Sex (boys/girls)
Weight (kg)
ASA I/II
Duration of procedure (min)

Group R (n = 32)
(mean ± SD)

Group F (n = 32)
(mean ± SD)

P-value*

9.7 ± 3.9

8.90 ± 4

0.417

11/21

16/16

0.255

26.96 ± 10.29

27.75 ± 11.58

0.773

27/5

26/6

0.970

9.21 ± 2.93

9.3 ± 2.29

0.898

ASA: American Society of Anesthesiologists. *: 95% confidence interval.
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Table 4. Intraoperative hemodynamic values.
Group R (n = 32)
SpO2 (%)

(mean ± SD)

Group F (n = 32)

(mean ± SD)

P-value

97.07 ± 0.90

96.6 ± 1.25

0.098

HR (beats min )

88.96 ± 10.94

94.15 ± 19.72

0.197

MAP (mmHg)

84.5 ± 9.11

84.87 ± 5.72

0.246

RR (breaths min–1)

14.66 ± 2.71

16.36 ± 1.69

0.03

–1

SpO2: peripheral oxygen saturation, HR: heart rate, MAP: mean arterial pressure, RR: respiratory rate.

the procedures. The difference between intraoperative
SpO2 measurements was not statistically significant (P >
0.05). Intraoperative RR, the time to awakening, opioid
consumption, and duration of PACU stay were significantly
shorter in group R than in group F (P < 0.05, Table 5).
The propofol consumption, movement score, and ease of
operation (endoscopist satisfaction) were similar between
groups (P > 0.05, Table 5). No postoperative complications
such as hypotension, bradycardia, bronchospasm, apnea,
or hypoxia were detected. Nausea was detected in 1 patient
in group R and in 3 patients in group F (P > 0.05).
4. Discussion
Endoscopy is a very effective practice in the diagnosis
and treatment of gastrointestinal diseases. Children and
uncooperative adults cannot tolerate the endoscopic
procedures without anesthetic support (2). Although
there is no ideal sedation protocol, intravenous sedation,
during which the child breathes spontaneously without an
artificial airway, is a frequently used technique. Propofol is
a potent and predictable IV anesthetic that can be used in
low doses to sedate children and it has been successfully
used in endoscopic procedures in children (2,7). However,
the sedative dose of propofol can easily be exceeded,
leading to unintended anesthesia and higher risk of
respiratory depression. To prevent respiratory depression,
propofol is slowly injected (16).
In this study, we tested the quality and safety of deep
sedation using a low induction dose of remifentanil or
standard dose of fentanyl in combination with propofol for
children undergoing an upper endoscopic procedure. Our
results showed that both remifentanil and fentanyl when
used at a dose of 0.25 µg kg–1 and 0.5 µg kg–1, respectively,
lead to satisfactory anesthesia with no severe complications
such as respiratory depression.
There are limited studies that compared the effectiveness
of the combination of remifentanil and fentanyl in children
undergoing endoscopic procedures (2,8,10,11).
Disma et al. studied the effect of the addition of
fentanyl to propofol and found that this hypnotic addition
leads to a significant decrease of used additional doses of
propofol (2). They also found that the addition of fentanyl
also increased the ease of the procedure. Their results were
comparable to our results; however, the dose of fentanyl
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in the present study was lower than in their study and our
remifentanil group provided a satisfactory sedation at a
low dose. Recovery time duration was also lower in the
present study compared to Disma et al.
In the prospective study of Abu-Shahwan and Mack
on 42 pediatric patients undergoing upper and lower
gastrointestinal endoscopy, they reported that propofol
and remifentanil infusion was very effective during the
procedure, providing good hemodynamic control and
fast recovery. The most definitive difference between their
study and the present study is the duration of procedure.
The complicated protocol reported in that study (after
sevoflurane induction, propofol was administered as 1 mg
kg–1 IV bolus and 80 µg kg–1 h–1 IV infusion was started,
then a second bolus of 1 mg kg–1 propofol was given before
the insertion of the endoscopy probe; propofol infusion
was reduced from 80 to 50 µg kg–1 min–1 5 min after the
start of the procedure; remifentanil infusion was begun at
0.1 µg kg–1 min–1 without a bolus dose and the infusion
of remifentanil was decreased to 0.05 µg kg–1 min–1 if the
respiratory rate was reduced to less than 10 breaths per
minute) might be appropriate for procedures with long
durations, but not for EGD. Our protocol is much simpler
and seems to be more appropriate for short procedures
such as EGD. The other important difference was that they
had given remifentanil as an IV infusion only, without a
premedication bolus dose. Although they did not report as
such, the usage of remifentanil as bolus treatment instead
of infusion may cause respiratory complications like apnea,
but this application is not appropriate for short-duration
procedures. In our protocol, apnea was observed after
induction in most patients, especially in the remifentanil
group. However, this situation was not significant clinically,
since spontaneous breathing started in all patients, either
by themselves or with a simple intervention. No apnea was
observed and SpO2 values were over 97% in both groups
during the procedure time period (11) (Table 4).
In anesthesia practice it is reported that the frequency
of apnea becomes higher in pediatric patients. In addition,
in children the incidence of perioperative complications
such as bronchospasm, apnea, airway obstruction, and
hypoventilation is expected to be higher as compared to
adults. Therefore, in pediatric patients, an anesthesiologist
who is experienced in airway management along with
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Table 5. Duration of apnea and recovery, perioperative drug dosages, and scores.
Group R (n = 32)
(mean ± SD) or n (%)

Group F (n = 32)
(mean ± SD) or n (%)

P-value

0.96 ± 0.99

1.12 ± 0.99

0.539

0

13

10

1

10

10

2

6

9

3

3

3

1.53 ± 0.62

1.93 ± 0.34

1

17

16

2

13

15

3

2

1

4

0

0

2.67 ± 0.77

2.74 ± 0.73

0.708

14

17

0.689

Time to awakening (min)*

10.78 ± 3.32

13.87 ± 3.0

0.0001

Duration of recovery (min)*

15.75 ± 5.11

21.39 ± 5.94

0.0001

Number of cases of apnea longer than 20 s

14 (43.75%)

11 (34.37%)

0.707

Duration of apnea (s)

26.56 ± 19.72

23.87 ± 20.45

0.592

Movement score

Ease of operation scores

Propofol consumption (mg kg–1)
Number of additional narcotic doses

0.913

*: Between groups, statistical significance at P < 0.05.

good monitoring could be said to be essential. Hassal, a
pediatric gastroenterologist, reported that the sedation
given by anesthesiologists was better in pediatric endoscopy
procedures in terms of patient safety and satisfaction (19).
There is only 1 study comparing propofol and fentanyl
with propofol and remifentanil in pediatric endoscopic
procedures. We studied the same 2 drugs but with different
doses and administration protocols.
Hirsh et al. compared the addition of remifentanil and
fentanyl to propofol during EGD practice and evaluated the
patient–endoscopist comfort, hemodynamic status, and
recovery times, and they concluded that the remifentanil
group had more efficient anesthesia but more respiratory
depression, and likewise in our results. In our study, half
of the dose of opioid used by Hirsh et al. for induction was
used, and we did not observe any decrease of SpO2 during
the procedure. In the study by Hirsh et al., intraoperative

mean SpO2 values were reported as 82.3% and 90% in
the remifentanil and fentanyl groups, respectively, but
in our study mean SpO2 values were 97.1% and 96.6%.
Although the recovery duration was similar to previous
studies that were reported before, in the present study, the
mean propofol consumption was lower, also. The reason
for this low consumption could be the simultaneous
administration of propofol and opioid together when
additional doses were needed. Recovery times in our study
were similar (8).
In conclusion, we consider that combinations of
propofol with remifentanil or fentanyl may provide safe
and practical anesthesia for outpatient procedures like
EGD in children. Low-dose induction with remifentanil
seems to be enough for providing the same anesthesia
quality with fentanyl without increasing the complication
rate in this group of children.

615

GÜL et al. / Turk J Med Sci
References
1.

Dilos BM. Anesthesia for pediatric airway endoscopy and
upper gastrointestinal endoscopy. Int Anesthesiol Clin 2009;
47: 55–62.

11.

Abu-Shahwan I, Mack D. Propofol and remifentanil for deep
sedation in children undergoing gastrointestinal endoscopy.
Paediatr Anaesth 2007; 17: 460–63

2.

Disma N, Astuto M, Rizzo G, Rosano G, Naso P, Aprile G
et al. Propofol sedation with fentanyl or midazolam during
oesophagogastroduodenoscopy in children. Eur J Anaest 2005;
22: 848–52.

12.

Berkenbosch JW, Graff GR, Stark JM, Ner Z, Tobias JD. Use of a
remifentanil-propofol mixture for pediatric flexible fiberoptic
bronchoscopy sedation. Paediatr Anaesth 2004; 14: 941–46.

13.

3.

Tolia V, Peters JM, Gilger MA. Sedation for pediatric
endoscopic procedures. J Pediatr Gastroenterol Nutr 2000; 30:
477–85.

4.

Tesniere A, Servin F. Intravenous techniques in ambulatory
anesthesia. Anesth Clin N Am 2003: 21; 273–88.

Niksch A, Liberman L, Clapcich A, Schwarzenberger JC, Silver
ES, Pass RH. Effects of remifentanil anesthesia on cardiac
electrophysiologic properties in children undergoing catheter
ablation of supraventricular tachycardia. Pediatr Cardiol 2010;
31: 1079–82.

14.

5.

Elitsur Y, Blankenship P, Lawrence Z. Propofol sedation for
endoscopic procedures in children. Endoscopy 2000; 32: 788–
91.

Foubert L, Reyntjens K, De Wolf D, Suys B, Moerman
A, Mortier E. Remifentanil infusion for cardiac catheterization
in children with congenital heart disease. Acta Anaesthesiol
Scand 2002; 46: 355–60.

6.

Krauss B, Green SM. Procedural sedation in children. Lancet
2006; 367: 766–80.

15.

7.

Amornyotın S, Aanpreung P, Prakarnrattana U, Chalayonnavin
W, Chatchawankitkul S, Srikureja W. Experience of intravenous
sedation for pediatric gastrointestinal endoscopy in a large
tertiary referral center in a developing country. Paediatr
Anaesth 2009; 19: 784–791.

But A, Arıkan M, Aslan B, Öztürk L, Tabuk M, Eyüp Horasanlı
E. Comparison of anesthesia with sevoflurane-N2O and
midazolam-remifentanil in low-birth-weight premature
infants undergoing diode laser photocoagulation. Turk J Med
Sci 2012; 42: 573–9.

16.

Uzun Ş, Özkaya BA, Yılbaş ÖS, Ayhan B, Şahin A, Aypar Ü.
Effects of different propofol injection speeds on blood pressure,
dose, and time of induction. Turk J Med Sci 2011; 41: 397–401.

17.

Barone CP, Pablo CS, Barone GW. Postanesthetic care in the
critical care unit. Crit Care Nurse 2004; 24: 38–45.

18.

Ceylan G, Yavaşcaoğlu B, Korfalı G, Kaya FN, Başağan Moğol
E, Türker G. A comparison of propofol and dexmedetomidine
on the effects of heamodynamy and cognitive functions
in conscious sedation during endoscopic retrograde
cholangiopancreatography. J Uludağ Univ Med Faculty 2010;
36: 103–10 (in Turkish with English abstract).

19.

Hassall E. Should pediatric gastroenterologists be i.v. drug
users? J Pediatr Gastroenterol Nutr 1993; 16: 370–2.

8.

Hirsh I, Lerner A, Shnaider I, Reuveni A, Pacht A, Segol O et al.
Remifentanil versus fentanyl for esophagogastroduodenoscopy
in children. J Pediatr Gastroenterol Nutr 2010; 51: 618–21.

9.

Xu ZY, Wang X, Si YY, Wu JC, Zuo YX, Xue FS et al. Intravenous
remifentanil and propofol for gastroscopy. J Clin Anesth 2008;
20: 352–55.

10.

Tosun Z, Aksu R, Guler G, Esmaoglu A, Akin A, Aslan D et
al. Propofol-ketamine vs propofol-fentanyl for sedation during
pediatric upper gastrointestinal endoscopy. Paediatr Anaesth
2007; 17: 983–88.

616

